Keystone Symposia on Fibrosis: Cross Organ Pathology and Pathways to Clinical Development, 2026
Advancing a Therapeutic Platform Based on tRNA Synthetases for Treatment of Fibrotic Lung Diseases
Federation of European Biochemical Societies: Expanding Frontiers in Aminoacyl-tRNA Synthetase Research, 2025
EFZO-FIT™: The Largest Ever Interventional Trial in Pulmonary Sarcoidosis
European Respiratory Society, 2025
Incidence, Prevalence, and Mortality of Pulmonary Sarcoidosis with Parenchymal Involvement in the US
American Thoracic Society, 2025
EFZO-FIT™, the Largest Placebo-Controlled Trial in Pulmonary Sarcoidosis
American Thoracic Society, 2025
Real-World Treatment Patterns Among Pulmonary Sarcoidosis Patients with Parenchymal Involvement
American Thoracic Society, 2025
ATYR0101: A New Approach to Fibrosis
American Thoracic Society Respiratory Innovation Summit, 2025
Immunosuppressive Myeloid Cells Can Be Modulated with NRP2-Targeting Antibody ATYR2810 Leading to Enhanced Anti-Tumor Immunity
American Association for Cancer Research, 2025
A Human Histidyl-tRNA Synthetase Splice Variant Therapeutic Targets NRP2 to Resolve Lung Inflammation and Fibrosis
Nangle LA, Xu Z, Siefker D, Burkart C, Chong YE, Zhai L, Geng Y, Polizzi C, Guy L, Eide L, Tong Y, Klopp-Savino S, Ferrer M, Rauch K, Wang A, Hamel K, Crampton S, Paz S, Chiang K, Do M, Burman L, Lee D, Zhang M, Ogilvie K, King D, Adams RA, Schimmel P.
Science Translational Medicine (2025)
Anti-Fibrotic Activity Observed Across Preclinical Models of Pulmonary and Renal Fibrosis for a Potential Therapeutic Based on Asp-tRNA Synthetase
Keystone Symposia on Fibrosis: Inflammation, Drivers, and Therapeutic Resolution, 2024